Aa Aa Aa

Sucampo is a global biopharmaceutical company focused on the development and commercialization of medicines to meet the major unmet medical needs of patients on a global basis.

Find out more.


  • September 29, 2014

    Sucampo and Takeda Launch Direct-to-Consumer Advertising Campaign for AMITIZA(R) (lubiprostone) for Chronic Idiopathic Constipation

  • August 21, 2014

    Sucampo Announces New Exclusive Global Manufacturing and Supply Agreement for Lubiprostone

  • August 5, 2014

    Sucampo Reports Second Quarter 2014 Financial Results and Corporate Update

  • July 23, 2014

    Sucampo Announces Publication of NICE Recommendation for AMITIZA(R) (Lubiprostone)